Compare Stocks: INBS, PETV, FEMY, and BEAT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BEAT HeartBeam	$0.43 -2.5%	$0.54	$0.40 ▼ $4.00	$24.57M	-0.8	1.02 million shs	64,863 shs
FEMY Femasys	$2.75 +2.6%	$3.14	$2.02 ▼ $22.20	$23.03M	-2.07	294,964 shs	19,813 shs
INBS Intelligent Bio Solutions	$2.18 +1.4%	$2.21	$1.52 ▼ $24.90	$6.60M	4.25	332,600 shs	18,577 shs
PETV PetVivo	$0.68	$0.71	$0.59 ▼ $1.69	$25.81M	1.36	10,484 shs	450 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BEAT HeartBeam	+4.33%	-2.07%	-14.97%	-41.68%	-67.50%
FEMY Femasys	-10.07%	-17.79%	+0.75%	-43.34%	-65.19%
INBS Intelligent Bio Solutions	-3.59%	-11.52%	+8.59%	-8.51%	-86.89%
PETV PetVivo	-2.94%	-2.94%	+1.54%	-17.47%	-19.90%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BEAT HeartBeam	$0.43 -2.5%	$0.54	$0.40 ▼ $4.00	$24.57M	-0.8	1.02 million shs	64,863 shs
FEMY Femasys	$2.75 +2.6%	$3.14	$2.02 ▼ $22.20	$23.03M	-2.07	294,964 shs	19,813 shs
INBS Intelligent Bio Solutions	$2.18 +1.4%	$2.21	$1.52 ▼ $24.90	$6.60M	4.25	332,600 shs	18,577 shs
PETV PetVivo	$0.68	$0.71	$0.59 ▼ $1.69	$25.81M	1.36	10,484 shs	450 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BEAT HeartBeam	+4.33%	-2.07%	-14.97%	-41.68%	-67.50%
FEMY Femasys	-10.07%	-17.79%	+0.75%	-43.34%	-65.19%
INBS Intelligent Bio Solutions	-3.59%	-11.52%	+8.59%	-8.51%	-86.89%
PETV PetVivo	-2.94%	-2.94%	+1.54%	-17.47%	-19.90%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BEAT HeartBeam	2.67	Moderate Buy	$4.00	798.27% Upside
FEMY Femasys	2.50	Moderate Buy	$50.00	1,765.67% Upside
INBS Intelligent Bio Solutions	1.50	Reduce	N/A	N/A
PETV PetVivo	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest INBS, PETV, FEMY, and BEAT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/18/2026	FEMY Femasys	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$10.00
8/17/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/14/2026	FEMY Femasys	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$10.00
7/31/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/17/2026	INBS Intelligent Bio Solutions	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/16/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/14/2026	BEAT HeartBeam	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$2.00
7/2/2026	BEAT HeartBeam	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/29/2026	INBS Intelligent Bio Solutions	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold

(Data available from 9/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BEAT HeartBeam	N/A	N/A	N/A	N/A	$0.06 per share	N/A
FEMY Femasys	$2.29M	9.81	N/A	N/A	$2.01 per share	1.33
INBS Intelligent Bio Solutions	$4.22M	1.54	N/A	N/A	$2.21 per share	0.97
PETV PetVivo	$1.05M	23.94	N/A	N/A	($0.03) per share	-22.00

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BEAT HeartBeam	-$21.01M	-$0.51	N/A	N/A	N/A	N/A	-686.78%	-348.65%	11/12/2026 (Estimated)
FEMY Femasys	-$18.63M	-$3.53	N/A	N/A	N/A	-534.36%	-225.97%	-74.68%	11/17/2026 (Estimated)
INBS Intelligent Bio Solutions	-$12.43M	-$9.02	N/A	N/A	N/A	-294.88%	-175.35%	-91.25%	11/11/2026 (Estimated)
PETV PetVivo	-$10.95M	-$0.34	N/A	N/A	N/A	-902.82%	-4,813.07%	-281.78%	11/12/2026 (Estimated)

Latest INBS, PETV, FEMY, and BEAT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/19/2026	Q4 2026	INBS Intelligent Bio Solutions	-$1.58	-$0.90	+$0.68	-$0.90	$1.22 million	$1.15 million
8/14/2026	Q2 2026	FEMY Femasys	-$1.31	-$1.33	-$0.02	-$1.33	$0.73 million	$0.33 million
8/13/2026	Q2 2026	BEAT HeartBeam	-$0.0860	-$0.10	-$0.0140	-$0.10	$0.15 million	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BEAT HeartBeam	N/A	N/A	N/A	N/A	N/A
FEMY Femasys	N/A	N/A	N/A	N/A	N/A
INBS Intelligent Bio Solutions	N/A	N/A	N/A	N/A	N/A
PETV PetVivo	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BEAT HeartBeam	N/A	3.66	3.61
FEMY Femasys	0.89	2.14	0.55
INBS Intelligent Bio Solutions	N/A	1.44	1.35
PETV PetVivo	0.02	0.42	0.47

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BEAT HeartBeam	7.77%
FEMY Femasys	65.27%
INBS Intelligent Bio Solutions	32.97%
PETV PetVivo	24.55%

Insider Ownership

Company	Insider Ownership
BEAT HeartBeam	17.95%
FEMY Femasys	7.75%
INBS Intelligent Bio Solutions	1.27%
PETV PetVivo	10.84%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BEAT HeartBeam	1,700	56.35 million	46.23 million	Not Optionable
FEMY Femasys	30	8.38 million	7.73 million	Not Optionable
INBS Intelligent Bio Solutions	10	3.03 million	2.99 million	Not Optionable
PETV PetVivo	20	37.95 million	19.06 million	Not Optionable

INBS, PETV, FEMY, and BEAT Headlines

Recent News About These Companies

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

September 8 at 1:10 PM | markets.businessinsider.com

PetVivo (NASDAQ:PETV) Stock Price Down 0.6% - Here's What Happened

September 3, 2026 | americanbankingnews.com

PetVivo Holdings, Inc.: Petvivo Holdings Announces Name Change Of Human Subsidiary To Somatrix Technologies, Inc. And Expands Focus On Human Health Innovation

August 20, 2026 | finanznachrichten.de

PETVIVO HOLDINGS ANNOUNCES NAME CHANGE OF HUMAN SUBSIDIARY TO SOMATRIX TECHNOLOGIES, INC. AND EXPANDS FOCUS ON HUMAN HEALTH INNOVATION

August 20, 2026 | finance.yahoo.com

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE 2026 FETCH KANSAS CITY VETERINARY CONFERENCE IN KANSAS CITY, MISSOURI

August 18, 2026 | jsonline.comJ

PetVivo Holdings, Inc.: PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027

August 15, 2026 | finanznachrichten.de

PetVivo Holdings, Inc. (PETV) Q1 2027 Earnings Call Transcript

August 14, 2026 | seekingalpha.com

PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027

August 14, 2026 | globenewswire.com

PetVivo Holdings, Inc.: Petvivo Holdings Announces Termination And Settlement Agreement With Vetstem

July 29, 2026 | finanznachrichten.de

PETVIVO HOLDINGS ANNOUNCES TERMINATION AND SETTLEMENT AGREEMENT WITH VETSTEM

July 28, 2026 | globenewswire.com

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE TEVA SUMMER CE SYMPOSIUM AT HORSESHOE BAY RESORT, TEXAS

July 21, 2026 | oklahoman.comO

PetVivo Holdings Inc.

July 20, 2026 | marketwatch.com

PetVivo Holdings Announces Publication of Peer-Reviewed Clinical Study Evaluating Spryng® in Veterinary Record

July 14, 2026 | globenewswire.com

PetVivo Holdings Inc (PETV) Q4 2026 Earnings Call Highlights: Navigating Growth Amidst Challenges

July 2, 2026 | finance.yahoo.com

PetVivo Holdings, Inc.: PetVivo Reports Financial and Operational Results for Fiscal 2026

June 30, 2026 | finanznachrichten.de

PetVivo Holdings, Inc. (PETV) Q4 2026 Earnings Call Prepared Remarks Transcript

June 29, 2026 | seekingalpha.com

PetVivo Reports Financial and Operational Results for Fiscal 2026

June 29, 2026 | globenewswire.com

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026

June 25, 2026 | globenewswire.com

PetVivo Holdings Announces Transformative Acquisition Of PiezoBioMembrane To Build a Leading Functional Biomaterials Platform

June 24, 2026 | globenewswire.com

PetVivo Holdings, Inc. (PETV) Discusses Spryng Technology Adoption and Commercial Expansion in Veterinary Practice Transcript

June 16, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

INBS, PETV, FEMY, and BEAT Company Descriptions

HeartBeam NASDAQ:BEAT

$0.43 -0.01 (-2.54%)

As of 10:31 AM Eastern

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.

Femasys NASDAQ:FEMY

$2.75 +0.07 (+2.61%)

As of 10:31 AM Eastern

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Intelligent Bio Solutions NASDAQ:INBS

$2.18 +0.03 (+1.40%)

As of 10:31 AM Eastern

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

PetVivo NASDAQ:PETV

$0.68 0.00 (0.00%)

As of 09:55 AM Eastern

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest INBS, PETV, FEMY, and BEAT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest INBS, PETV, FEMY, and BEAT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

INBS, PETV, FEMY, and BEAT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

INBS, PETV, FEMY, and BEAT Company Descriptions

HeartBeam NASDAQ:BEAT

Femasys NASDAQ:FEMY

Intelligent Bio Solutions NASDAQ:INBS

PetVivo NASDAQ:PETV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest INBS, PETV, FEMY, and BEAT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest INBS, PETV, FEMY, and BEAT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

INBS, PETV, FEMY, and BEAT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

INBS, PETV, FEMY, and BEAT Company Descriptions

HeartBeam NASDAQ:BEAT

Femasys NASDAQ:FEMY

Intelligent Bio Solutions NASDAQ:INBS

PetVivo NASDAQ:PETV

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools